Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.

ABSTRACT:

SUBMITTER: Dhakal B 

PROVIDER: S-EPMC7176050 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature